Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026)
Canton Strategic Holdings (CNTN) reported Operating Expenses of $36.9 million for Q1 2026, up 1347.71% on a YoY basis from $2.5 million in Q1 2025, and up 170.8% quarter-over-quarter from $13.6 million in Q4 2025.
Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Operating Expenses for 6 years, with the latest figure at $36.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 1347.71% year-over-year to $36.9 million; the trailing twelve-month figure through Mar 2026 stood at $54.4 million (up 330.83% YoY), and the FY2025 full-year result was $20.1 million, up 61.71% from the prior year.
- Operating Expenses for Q1 2026 stood at $36.9 million, up from $13.6 million in the prior quarter.
- The five-year high for Operating Expenses was $36.9 million in Q1 2026, with the low at $1.4 million in Q1 2022.
- Historically, Operating Expenses has averaged $5.0 million across 5 years, with a median of $2.4 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 1638.74% — and 2025, when it plunged 45.84%.
- Canton Strategic Holdings' Operating Expenses stood at $1.8 million in 2022, then soared by 43.29% to $2.5 million in 2023, then soared by 52.0% to $3.8 million in 2024, then soared by 253.86% to $13.6 million in 2025, then surged by 170.8% to $36.9 million in 2026.
- The last three Operating Expenses figures came in at $36.9 million (Q1 2026), $13.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.87 Mn |
| Dec 31, 2025 | 13.61 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 101,593.00 |
| Sep 30, 2021 | 541,113.00 |
| Jun 30, 2021 | 1.10 Mn |